Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Identify whether an SP 500 ETF or index fund better suits your retirement plan, focusing on costs and long-term goals.
25,310 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Micron has bounced around the market, but its long-term growth story is coming into sharper focus. This article expla...
Oklo stock surged as investors weighed its plans for advanced reactors against the fast-moving AI data-center boom. T...
A thoughtful look at what a July price milestone could mean for SpaceX in a hypothetical IPO scenario. Learn how to a...
Inflation is back, and 2026 could test investors in new ways. This guide breaks down what inflation surging: here's t...
As lithium demand climbs, Albemarle sits at a crossroads. This article breaks down the lithium rise again. does dynam...
The semiconductor rally has investors eyeing Intel ahead of its July 23 report. This guide breaks down whether you sh...
Momentum can flip quickly in growth stocks, but today some names look cheap for the upside potential. This guide high...
SanDisk stock is sinking today, but what does it mean for your investments? This guide breaks down the drivers, adds ...
Investors are sizing up whether prediction: micron technology stock could jump after the June 24 earnings reveal. Thi...
In 2026, Marvell Technology has become a focal point for investors. This article breaks down the drivers behind the r...
Adobe Stock sits at a crossroads as the company leans into AI, subscriptions, and enterprise workflows. This guide ex...